CapEx at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s capex?
- Dyne Therapeutics, Inc. (DYN) reported capex of $221K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s capex changed year-over-year?
- Dyne Therapeutics, Inc.'s capex decreased by 77.5% year-over-year, from $981K to $221K.
- What is the long-term trend for Dyne Therapeutics, Inc.'s capex?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s capex has grown at a -14.6% compound annual growth rate (CAGR), from $3.62M to $1.92M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.